Daiichi Sankyo Co Limited Sponsored Adr News, Daiichi Sankyo Co Limited Sponsored Adr Quote, DSNKY Quote

Daiichi Sankyo Co Limited Sponsored Adr (OP:DSNKY) Delayed: 18.09 +0.60 (3.43%)

Prev. Close

$17.49

Today 6M 1Y 5Y

Open

$18.49

52 Wk High

$26.24

52 Wk Low

$18.86

Day High

$18.68

Day Low

$18.09

P/E

N/A

EPS

$0.00

Volume

139,481

Friends, Peers and Foes (?): AZN, 4568:JP, MRK, CGEN NUVB (more...)

ALERTS | RSS

Aug 28, 2026 04:00 AM New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk
Aug 27, 2026 07:00 AM DS1025 Enters Clinical Development in Patients with Advanced Solid Tumors as Novel CD25 Directed ADC in Industry-Leading ADC Portfolio of Daiichi Sankyo
Aug 26, 2026 07:00 AM Daiichi Sankyo and AstraZeneca start phase 3 urothelial cancer trial
Aug 26, 2026 07:00 AM TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer
Aug 24, 2026 04:00 AM Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization
Aug 24, 2026 03:00 AM Daiichi Sankyo Appoints Ken Keller as Chief Commercialization Officer to Lead New Commercialization Unit to Accelerate Growth of Innovative Portfolio
Aug 17, 2026 02:30 AM Enhertu meets main goal in phase 3 lung cancer trial
Aug 17, 2026 02:30 AM Enhertu® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival as First-Line Treatment of Patients with HER2 Mutant Advanced Non-Small Cell Lung Ca
Aug 6, 2026 06:31 AM Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Raised to JPY4,900 at Citi
Aug 4, 2026 06:59 AM Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Lowered to JPY4,300 at Macquarie

Entities mentioned with DSNKY

View All Entities